Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Trimira Provides Update On Identafi 3000 Ultra

An oral cancer detection device that uses triple-wavelength fluorescence and reflectance optical system

Trimira has said that its Identafi 3000 oral cancer detection device has detected oral cancer in at least one member of the public who participated in the free oral cancer screening held at Saratoga Race Course in July. The company claims it to be the world’s first oral cancer screening tool to use a patented triple-wavelength (multispectral) fluorescence and reflectance optical system.

Trimira’s device uses white, violet, and green-amber wavelengths of light to excite oral tissue in distinct ways. It enables those on the front line of detection to catch early indicators and stages of oral cancer and pre-cancer that are missed by the naked eye.

The racetrack oral cancer screenings were conducted using Identafi detection device, which features the high-speed, high-resolution optical processing technologies. Identafi 3000 ultra is a portable handheld that incorporates advances in cancer detection from research scientists at The University of Texas, RiceUniversity, and British Columbia Cancer Research Centre, said the company.